Sean McCutcheon's Stock Ratings

Raymond James Analyst

Sean McCutcheon is an analyst at Raymond James. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/17/2025

Updated: Dec 17, 2025

Overall Average Return

1.78%

Smart Score

44.4%

Overall Average Return Percentile

37th

Number of Ratings

11
Buy NowGet Alert
10/17/2025RVMDBuy Now
Revolution Medicines
$75.800.26%$72 → $76MaintainsStrong BuyGet Alert
09/12/2025RVMDBuy Now
Revolution Medicines
$75.80-5.01% → $72Assumes → Strong BuyGet Alert
07/11/2025VIRBuy Now
Vir Biotechnology
$6.1595.12% → $12Initiates → OutperformGet Alert
07/11/2025JANXBuy Now
Janux Therapeutics
$14.10360.99% → $65Initiates → OutperformGet Alert
07/01/2025CMPXBuy Now
Compass Therapeutics
$4.8585.48% → $9Reinstates → OutperformGet Alert
07/01/2025BDTXBuy Now
Black Diamond Therapeutic
$2.59324.71% → $11Reinstates → OutperformGet Alert
11/27/2024ENGNBuy Now
enGene Holdings
$7.80194.87% → $23Initiates → OutperformGet Alert
06/14/2024XNCRBuy Now
Xencor
$15.40159.74%$58 → $40MaintainsStrong BuyGet Alert
05/23/2024CYTKBuy Now
Cytokinetics
$58.5019.66%$92 → $70MaintainsOutperformGet Alert
03/13/2024LEGNBuy Now
Legend Biotech
$21.49300.19% → $86Initiates → OutperformGet Alert
12/28/2023CYTKBuy Now
Cytokinetics
$58.5057.26%$63 → $92MaintainsOutperformGet Alert